With new high quality study results from the fields of mobility, body toning, beauty-from-within and wound healing, GELITA strengthens its position as a preferred partner for the development of innovative supplements and functional food products with proven efficacy.
At the show, the company will also present RXL R2, a gelatin for soft capsules with revolutionary fast fill release performance.
With their special nutritional and technological properties, Bioactive Collagen Peptides are enjoying increasing popularity in the food and dietary supplements market.
New research on knee pain reduction in athletes and osteoporosis prevention in postmenopausal women has once again underlined the effectiveness of FORTIGEL and FORTIBONE.
By stimulating the body’s own cells to strengthen the structure of joints and bones, these specific collagen peptides operate from within and help people to stay active and mobile at every life stage.
Further, a recent study with GELITA’s BODYBALANCE revealed a significant increase in fat-free body mass after resistance exercise and supplementation compared with a placebo. Collagen peptide treatment led to significant fat mass reduction, whereas muscle strength and waist circumference improved after intake.
By influencing collagen metabolism directly from the inside, VERISOL gives the skin its firm structure and is essential for skin elasticity and resistance.
That it can also improve the wound healing process after surgery has now been shown in novel research. Patients treated with VERISOL clearly showed better wound healing results than the placebo group.
Besides collagen peptides, GELITA also offers various grades of pharmaceutical gelatin. At Vitafoods, the company’s Pharmaceutical Competence Team will present its latest development: GELITA RXL R2, a product that takes the reduced cross-linking concept provided by GELITA RXL one step further and brings revolutionary release (R2) performance to the market (three times faster fill release compared with standard gelatin).
Trials clearly show that even under demanding storage conditions (6 months at 40 °C and 75% rh), capsules made with GELITA RXL R2 demonstrate the same fill release profiles as recently produced ones.